A phase II trial evaluating the feasibility of adding bevacizumab to standard osteosarcoma therapy
一项评估在标准骨肉瘤治疗方案中加入贝伐单抗可行性的II期临床试验
期刊:International Journal of Cancer
影响因子:4.7
doi:10.1002/ijc.30841
Navid, Fariba; Santana, Victor M; Neel, Michael; McCarville, M Beth; Shulkin, Barry L; Wu, Jianrong; Billups, Catherine A; Mao, Shenghua; Daryani, Vinay M; Stewart, Clinton F; Kunkel, Michelle; Smith, Wendene; Ward, Deborah; Pappo, Alberto S; Bahrami, Armita; Loeb, David M; Reikes Willert, Jennifer; Rao, Bhaskar N; Daw, Najat C